Question 1

What is the share price of Marksans Pharma Limited today?

Accepted Answer

Marksans Pharma Limited (MARKSANS) is trading at ₹315.35. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is MARKSANS’s P/E ratio versus the sector?

Accepted Answer

MARKSANS trades at a P/E of 49.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is MARKSANS’s dividend yield?

Accepted Answer

MARKSANS has a dividend yield of 0.26%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is MARKSANS’s 52-week high and low?

Accepted Answer

MARKSANS has traded between ₹155 and ₹350.95 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Marksans Pharma Limited?

Accepted Answer

Marksans Pharma Limited has a market capitalisation of ₹15,752 crore.

Question 6

What is MARKSANS’s return on equity?

Accepted Answer

MARKSANS reports a return on equity of 19.7%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - General.

Question 7

Who are MARKSANS’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - General companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is MARKSANS’s promoter holding?

Accepted Answer

Promoters hold 43.87% of MARKSANS. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include MARKSANS?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight MARKSANS carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Marksans Pharma Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from MARKSANS’s own numbers. The judgement is yours.

MARKSANS

MARKSANS

Value & Investment Index

VII Detail

Multiples vs Peers

Quality Scores

Versus Its Own History

Scenario analysis

MARKSANS valuation summary

P/E	49.0
ROE	19.7%
ROCE	25.6%
Dividend yield	0.26%